Only 34% of Americans trust physicians

Cara Livernois | | Health Exec | Cybersecurity

Trust in physicians and medical leaders has steadily declined over the past few decades, with only a quarter of Americans having confidence in the healthcare system.

Those who trust their providers are often healthier than those who don’t. According to the New York Times, trust in physicians has fallen from three-fourths in 1966 to 34 percent today. More notably, only a third of Americans trust the healthcare system to provide accurate information in the event of an outbreak.

Another possible reason for this decline is the uncertainty about a healthcare system's ability to ensure the security and privacy of patient’s electronic medical records and personal data. This barrier to physician trust extends into telehealth utilization as patients are unsure on the accuracy of diagnosis made through a screen rather than in person.

Read the full story below:

Do You Trust the Medical Profession?

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

FBI seeking extradition of Israeli prisoner accused of $500M in ransomware attacks
Data breach at chain of clinics impacts 450K patients
Nebraska becomes first state to sue Change Healthcare over data breach
Christmas ransomware exposed over 300K patient records to dark web
Cryo-frozen tissue manufacturer suffers cyberattack
First surgical device of its kind granted key FDA exemption

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.